Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
38
Named actors
13
Disclosed $ (bull / bear)
$0 / $93.3M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-12 | Affiliate (via BTIG LLC) RA Capital Nexus Fund III, L.P. | filed notice to sell | $36.0M | SEC ↗ |
| 2026-08-12 | affiliate (via BTIG LLC) RA Capital Healthcare Fund LP | filed notice to sell | $36.0M | SEC ↗ |
| 2026-08-12 | 10% Stockholder (via Raymond James & Associates) Third Rock Ventures V, L.P. | filed notice to sell | $7.5M | SEC ↗ |
| 2026-08-11 | President and COO Bhatt Elizabeth | sold | $1.1M | SEC ↗ |
| 2026-08-11 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ELIZABETH P. BHATT | filed notice to sell | $1.1M |
13 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| SEC ↗ |
| 2026-08-03 | SVP, Drug Discovery Long Daniel D. | sold | $81K | SEC ↗ |
| 2026-08-03 | SVP, Drug Discovery Long Daniel D. | sold | $34K | SEC ↗ |
| 2026-07-15 | President and COO Bhatt Elizabeth | sold | $136K | SEC ↗ |
| 2026-07-15 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) ELIZABETH P. BHATT | filed notice to sell | $138K | SEC ↗ |
| 2026-07-01 | SVP, Drug Discovery Long Daniel D. | sold | $72K | SEC ↗ |
| 2026-07-01 | SVP, Drug Discovery Long Daniel D. | sold | $43K | SEC ↗ |
| 2026-06-29 | Chief People Officer Shaikhly Samira | sold | $77K | SEC ↗ |
| 2026-06-26 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JAE KIM | filed notice to sell | $89K | SEC ↗ |
| 2026-06-22 | SVP, Drug Discovery Long Daniel D. | sold | $252K | SEC ↗ |
| 2026-06-22 | SVP, Drug Discovery Long Daniel D. | sold | $281K | SEC ↗ |
| 2026-06-22 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) JAE KIM | filed notice to sell | $3.3M | SEC ↗ |
| 2026-06-22 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) DANIEL LONG | filed notice to sell | $904K | SEC ↗ |
| 2026-06-12 | Chief People Officer Shaikhly Samira | sold | $219K | SEC ↗ |
| 2026-06-12 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) SAMIRA SHAIKHLY | filed notice to sell | $287K | SEC ↗ |
| 2026-06-01 | Chief People Officer Shaikhly Samira | sold | $47K | SEC ↗ |
| 2026-06-01 | Chief People Officer Shaikhly Samira | sold | $86K | SEC ↗ |
| 2026-06-01 | Chief People Officer Shaikhly Samira | sold | $39K | SEC ↗ |
| 2026-05-26 | Chief People Officer Shaikhly Samira | sold | $355K | SEC ↗ |
| 2026-05-26 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) SAMIRA SHAIKHLY | filed notice to sell | $335K | SEC ↗ |
| 2026-04-15 | President and COO Bhatt Elizabeth | sold | $8K | SEC ↗ |